Home › Crohn's Disease › Washington › Tacoma
Crohn's Disease clinical trials in Tacoma, WA
11 studies for Crohn's Disease are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecruitingPhase 3
- Washington Gastroenterology - Tacoma ( Site 5004), Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2/3
- GI Alliance Tacoma, Tacoma
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RecruitingPhase 2
- Washington Gastroenterology - Tacoma /ID# 267302, Tacoma
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RecruitingPhase 4
- Washington Gastroenterology- GIA, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RecruitingPhase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- GI Alliance Tacoma, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
RecruitingPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Tacoma
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Boston, MA19 studies
- St. Louis, MO19 studies
- Miami, FL19 studies
- Cleveland, OH18 studies
- Orlando, FL17 studies
- Atlanta, GA17 studies
- Houston, TX17 studies
- Tyler, TX16 studies
- Los Angeles, CA15 studies
- San Diego, CA15 studies
- San Antonio, TX15 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer18 studies
- Ulcerative Colitis15 studies
- Multiple Myeloma13 studies
- Prostate Cancer11 studies
- Metastatic Cancer9 studies
- Colorectal Cancer9 studies
- Melanoma7 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer6 studies
- Obesity6 studies
- Stomach Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.